Crypto

Samsung Bioepis Achieves International Recognition with ISO 37301 Certification for Compliance Management

Samsung Bioepis Celebrates ISO 37301 Certification

Samsung Bioepis has proudly received the ISO 37301 certification from the International Organization for Standardization (ISO), marking a significant milestone in its commitment to compliance and ethical business practices. The certification ceremony, held at the Samsung Bioepis headquarters, was attended by key figures including CEO Kim Kyung-ah and representatives from the British Standards Institution (BSI).

Samsung Bioepis CEO Kim Kyung-ah (left) and BSI representatives (right) at the ISO 37301 certification ceremony

Understanding ISO 37301

ISO 37301 is an international standard that evaluates a company's internal processes for managing compliance risks and adhering to legal and ethical standards. Samsung Bioepis' achievement underscores its dedication to maintaining a robust compliance management system and fostering a sustainable ethical culture.

A Commitment to Global Standards

CEO Kim Kyung-ah emphasized the importance of building a compliance system based on international standards to strengthen trust with global partners and customers. This certification is a testament to Samsung Bioepis' ongoing efforts to lead with integrity and compliance in the biopharmaceutical industry.

By Business Korea Kim Hyun-min ([email protected])